BONO, FRANCESCO GIUSEPPE
 Distribuzione geografica
Continente #
AS - Asia 217
NA - Nord America 148
EU - Europa 144
SA - Sud America 26
AF - Africa 4
Totale 539
Nazione #
US - Stati Uniti d'America 142
SG - Singapore 114
IT - Italia 52
CN - Cina 40
DE - Germania 35
IN - India 28
BR - Brasile 20
FI - Finlandia 19
VN - Vietnam 13
SE - Svezia 8
JP - Giappone 7
EE - Estonia 6
BD - Bangladesh 5
CA - Canada 5
AR - Argentina 4
FR - Francia 4
GB - Regno Unito 4
HK - Hong Kong 4
IE - Irlanda 4
AT - Austria 3
PL - Polonia 3
ZA - Sudafrica 3
CZ - Repubblica Ceca 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
DZ - Algeria 1
ES - Italia 1
IQ - Iraq 1
LT - Lituania 1
MX - Messico 1
NL - Olanda 1
PE - Perù 1
PS - Palestinian Territory 1
TR - Turchia 1
VE - Venezuela 1
Totale 539
Città #
Singapore 57
Munich 29
Santa Clara 22
Los Angeles 19
Bengaluru 18
Hefei 17
Dallas 16
Turku 16
Milan 15
Ashburn 12
Ho Chi Minh City 8
Tokyo 7
Lawrence 5
Montreal 5
Princeton 5
Beijing 4
Dublin 4
Hong Kong 4
Tremestieri Etneo 4
Adelfia 3
Asti 3
Boardman 3
Chandler 3
Helsinki 3
Johannesburg 3
London 3
New Delhi 3
Rende 3
San Francisco 3
São Paulo 3
Assago 2
Borgia 2
Boston 2
Brooklyn 2
Buffalo 2
Casoria 2
Chennai 2
Curitiba 2
Des Moines 2
Ginosa 2
Nuremberg 2
Olomouc 2
Palo del Colle 2
Phoenix 2
Reggio Calabria 2
Rome 2
Shenzhen 2
Stockholm 2
Tashkent 2
Turin 2
Warsaw 2
Xian 2
Amsterdam 1
Ankara 1
Baghdad 1
Barbacena 1
Barretos 1
Bhanga 1
Bismarck 1
Bordj el Kiffan 1
Brasília 1
Buenos Aires 1
Can Tho 1
Caracas 1
Chicago 1
Chihuahua City 1
Clearwater 1
Criciúma 1
Da Nang 1
Denver 1
Duque de Caxias 1
Guarulhos 1
Jacareí 1
Jalandhar 1
Jinan 1
Jinhua 1
Keswick 1
Miami 1
Mumbai 1
Narsingdi 1
New York 1
Norwalk 1
Olivos 1
Ourinhos 1
Paraíba do Sul 1
Paris 1
Parobé 1
Patna 1
Prineville 1
Ramallah 1
Recife 1
Rio de Janeiro 1
San Jose 1
San Miguel de Tucumán 1
Sanford 1
Santa Luzia 1
Santo André 1
Sofia 1
Somma Vesuviana 1
Southbury 1
Totale 392
Nome #
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 60
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 44
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 42
Neurological manifestations in patients and disease carriers in an Italian family with osteosclerosis 40
Regional Targeted Subcutaneous Injection of Botulinum Neurotoxin Type A in Refractory Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study 38
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 38
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 30
Periventricular white matter changes in idiopathic intracranial hypertension 29
Clinical Correlates of Functional Motor Disorders: An Italian Multicenter Study 28
Brainstem changes causing reversible RBD in patients with spontaneous intracranial hypotension: a longitudinal neuroimaging study 28
Parkinsonism during treatment with sodium valproate: A case report 27
An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease? 26
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 26
Effects of alcohol on ocular motor abnormalities in Ramsay-Hunt syndrome 25
HEADWORK Questionnaire: Why Do We Need a New Tool to Assess Work-Related Disability in Patients With Migraine? 23
Correction to: A video of best practice recommendations for making botulinum toxin therapy safe during the COVID?19 pandemic (Neurological Sciences, (2021), 42, 9, (3937-3938), 10.1007/s10072-021-05375-z) 22
Effect of mannitol bolus administration on cerebrospinal fluid pressure in patients with idiopathic intracranial hypertension: a pilot study 19
Mannitol effectiveness in lowering intracranial pressure in idiopathic intracranial hypertension: A case series 18
Intraventricular tumor presenting as progressive supranuclear palsy-like phenotype 10
Totale 573
Categoria #
all - tutte 5.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 4 0 1 0 0 3 0 0
2021/202216 0 1 0 3 4 0 0 3 1 1 3 0
2022/202321 10 0 3 0 0 0 4 1 1 2 0 0
2023/202439 4 11 5 2 4 3 0 0 5 0 2 3
2024/2025266 38 16 8 3 12 37 6 7 31 9 42 57
2025/2026220 38 51 27 42 62 0 0 0 0 0 0 0
Totale 573